Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SLV vs MRNA✓SelectedUSD · MRNASLV vs MRNA performance historyLatest closeAs of-3.94%11/16
Stock and ETF performance explorer

SLV vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-6.8%
MRNA return
+778.7%
Excess return
-785.4%
Maximum drawdown
-59.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.9%-3.6%-0.3%-3.8%
7D-11.9%-20.0%+8.0%-10.9%
30D-17.7%-1.3%-16.4%-17.7%
3M-27.5%+240.0%-267.5%-34.4%
6M-38.6%+339.0%-377.6%-48.8%
YTD-34.2%+630.0%-664.2%-48.4%
All-6.8%+778.7%-785.4%-29.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling